| Entry |
|
|---|
| Name |
Pargyline hydrochloride (USAN);
Eutonyl (TN) |
|---|
| Formula |
C11H13N. HCl
|
|---|
| Exact mass |
195.0815
|
|---|
| Mol weight |
195.6886
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidepressant, Antihypertensive, Monoamine oxidase (MAO) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07216 | Catecholamine transferase inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02K OTHER ANTIHYPERTENSIVES
C02KC MAO inhibitors
C02KC01 Pargyline
D02564 Pargyline hydrochloride (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00264 Pargyline
D02564 Pargyline hydrochloride
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAO
D02564 Pargyline hydrochloride (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00264 Pargyline
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 13
1 C8y C 11.6200 -15.4700
2 C1b C 12.8100 -14.7700
3 C8x C 11.6200 -16.8700
4 C8x C 10.4300 -14.7700
5 N1c N 14.0700 -15.4700
6 C8x C 10.4300 -17.5700
7 C8x C 9.2400 -15.4700
8 C1b C 15.2600 -14.7700
9 C1a C 14.0700 -16.8700
10 C8x C 9.2400 -16.8700
11 C3b C 16.4500 -15.4700
12 C3a C 17.7100 -16.1700
13 X Cl 22.6100 -16.1700
BOND 12
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 1
8 5 9 1
9 6 10 1
10 8 11 1
11 11 12 3
12 7 10 2
|
|---|
